# Travoprost Five Day Posology Study

> **NCT01114893** · PHASE2 · COMPLETED · sponsor: **Alcon Research** · enrollment: 60 (actual)

## Conditions studied

- Open-angle Glaucoma (OAG)
- Ocular Hypertension

## Interventions

- **DRUG:** Travoprost 0.004%
- **DRUG:** Travoprost Vehicle
- **DRUG:** Travoprost (Groups A, B and C)

## Key facts

- **NCT ID:** NCT01114893
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-05
- **Final completion:** —
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01114893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01114893, "Travoprost Five Day Posology Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01114893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*